Overview

A Study to Evaluate the Efficacy and Safety of BR1019A and BR1019B Combination Therapy

Status:
RECRUITING
Trial end date:
2025-04-01
Target enrollment:
Participant gender:
Summary
The objective of this clinical study is to Evaluate the Efficacy and Safety of BR1019A and BR1019B combination therapy in Patients with Essential Hypertension and Type 2 Diabetes Mellitus
Phase:
PHASE3
Details
Lead Sponsor:
Boryung Pharmaceutical Co., Ltd